Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02077959 · TERMINATED
Trial details
- NCT number
- NCT02077959
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-03
- Primary completion
- 2019-05-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.